Suppr超能文献

在预先用GR 127935处理并切除迷走交感神经的犬中,假定的5-羟色胺7受体介导5-羟色胺诱导的颈外血管舒张。

Mediation of 5-HT-induced external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptor.

作者信息

Villalón C M, Centurión D, Luján-Estrada M, Terrón J A, Sánchez-López A

机构信息

Departamento de Farmacología y Toxicología, CINVESTAV, México D.F.

出版信息

Br J Pharmacol. 1997 Apr;120(7):1319-27. doi: 10.1038/sj.bjp.0701020.

Abstract
  1. The vasodilator effects of 5-hydroxytryptamine (5-HT) in the external carotid bed of anaesthetized dogs with intact sympathetic tone are mediated by prejunctional sympatho-inhibitory 5-HT1B/1D receptors and postjunctional 5-HT receptors. The prejunctional vasodilator mechanism is abolished after vagosympathectomy which results in the reversal of the vasodilator effect to vasoconstriction. The blockade of this vasoconstrictor effect of 5-HT with the 5-HT1B/1D receptor antagonist, GR 127935, unmasks a dose-dependent vasodilator effect of 5-HT, but not of sumatriptan. Therefore, the present study set out to analyse the pharmacological profile of this postjunctional vasodilator 5-HT receptor in the external carotid bed of vagosympathectomized dogs pretreated with GR 127935 (20 micrograms kg-1, i.v.). 2. One-minute intracarotid (i.c.) infusions of 5-HT (0.3-30 micrograms min-1), 5-carboxamidotryptamine (5-CT; 0.01-0.3 microgram min-1), 5-methoxytryptamine (1-100 micrograms min-1) and lisuride (3-1000 micrograms min-1) resulted in dose-dependent increases in external carotid blood flow (without changes in blood pressure or heart rate) with a rank order of agonist potency of 5-CT > > 5-HT > or = 5-methoxytryptamine > lisuride, whereas cisapride (100-1000 micrograms min-1, i.c.) was practically inactive. Interestingly, lisuride (mean dose of 85 +/- 7 micrograms kg-1, i.c.), but not cisapride (mean dose of 67 +/- 7 micrograms kg-1, i.c.), specifically abolished the responses induced by 5-HT, 5-CT and 5-methoxytryptamine, suggesting that a common site of action may be involved. In contrast, 1 min i.c. infusions of 8-OH-DPAT (3-3000 micrograms min-1) produced dose-dependent decreases, not increases, in external carotid blood flow and failed to antagonize (mean dose of 200 +/- 33 micrograms kg-1, i.c.) the agonist-induced vasodilator responses. 3. The external carotid vasodilator responses to 5-HT, 5-CT and 5-methoxytryptamine were not modified by intravenous (i.v.) pretreatment with either saline, (+/-)-pindolol (4 mg kg-1) or ritanserin (100 micrograms kg-1) plus granisetron (300 micrograms kg-1), but were dose-dependently blocked by i.v. administration of methiothepin (10 and 30 micrograms kg-1, given after ritanserin plus granisetron), mesulergine (10 and 30 micrograms kg-1), metergoline (1 and 3 mg kg-1), methysergide (1 and 3 mg kg-1) or clozapine (0.3 and 1 mg kg-1). Nevertheless, the blockade of the above responses, not significant after treatment with the lower of the two doses of metergoline and mesulergine, was nonspecific after administration of the higher of the two doses of methysergide and clozapine. 4. Based upon the above rank order of agonist potencies and the antagonism produced by a series of drugs showing high affinity for the cloned 5-ht7 receptor, our results indicate that the 5-HT receptor mediating external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs is operationally similar to the putative 5-HT7 receptor mediating relaxation of vascular and non-vascular smooth muscles (e.g. rabbit femoral vein, canine coronary artery, rat systemic vasculature and guinea-pig ileum) as well as tachycardia in the cat.
摘要
  1. 在交感神经张力完整的麻醉犬的颈外动脉床中,5-羟色胺(5-HT)的血管舒张作用由节前交感抑制性5-HT1B/1D受体和节后5-HT受体介导。迷走交感神经切除术后,节前血管舒张机制被消除,导致血管舒张作用逆转为血管收缩。用5-HT1B/1D受体拮抗剂GR 127935阻断5-HT的这种血管收缩作用后,可揭示5-HT(而非舒马曲坦)的剂量依赖性血管舒张作用。因此,本研究旨在分析在用GR 127935(20微克/千克,静脉注射)预处理的迷走交感神经切除犬的颈外动脉床中,这种节后血管舒张性5-HT受体的药理学特征。2. 颈内动脉(i.c.)内1分钟输注5-HT(0.3 - 30微克/分钟)、5-羧酰胺色胺(5-CT;0.01 - 0.3微克/分钟)、5-甲氧基色胺(1 - 100微克/分钟)和利舒脲(3 - 1000微克/分钟)导致颈外动脉血流量呈剂量依赖性增加(血压和心率无变化),激动剂效力顺序为5-CT >> 5-HT ≥ 5-甲氧基色胺 > 利舒脲,而西沙必利(100 - 1000微克/分钟,i.c.)实际上无活性。有趣的是,利舒脲(平均剂量85 ± 7微克/千克,i.c.)而非西沙必利(平均剂量67 ± 7微克/千克,i.c.)能特异性消除5-HT、5-CT和5-甲氧基色胺诱导的反应,提示可能涉及共同作用位点。相比之下,颈内动脉内1分钟输注8-羟基二丙胺基四氢萘(8-OH-DPAT,3 - 3000微克/分钟)导致颈外动脉血流量呈剂量依赖性减少而非增加,且未能拮抗(平均剂量200 ± 33微克/千克,i.c.)激动剂诱导的血管舒张反应。3. 颈外动脉对5-HT、5-CT和5-甲氧基色胺的血管舒张反应不受静脉注射(i.v.)生理盐水、(±)-吲哚洛尔(4毫克/千克)或利坦色林(100微克/千克)加格拉司琼(300微克/千克)预处理的影响,但静脉注射甲硫噻嗪(10和30微克/千克,在利坦色林加格拉司琼后给予)、麦角新碱(10和30微克/千克)、美替拉酮(1和3毫克/千克)、甲基麦角新碱(1和3毫克/千克)或氯氮平(0.3和1毫克/千克)可使其剂量依赖性阻断。然而,用较低剂量的美替拉酮和麦角新碱治疗后上述反应的阻断不显著,而用较高剂量的甲基麦角新碱和氯氮平给药后则是非特异性的。4. 根据上述激动剂效力顺序以及一系列对克隆的5-HT₇受体具有高亲和力的药物产生的拮抗作用,我们的结果表明,在经GR 127935预处理的迷走交感神经切除犬中,介导颈外动脉血管舒张的5-HT受体在功能上类似于介导血管和非血管平滑肌舒张(如兔股静脉、犬冠状动脉、大鼠全身血管系统和豚鼠回肠)以及猫心动过速的假定5-HT₇受体。

相似文献

引用本文的文献

6
The 5-HT7 receptor and disorders of the nervous system: an overview.5-HT7 受体与神经系统疾病:概述。
Psychopharmacology (Berl). 2009 Oct;206(3):345-54. doi: 10.1007/s00213-009-1626-0. Epub 2009 Aug 1.
9
Dilatation induced by 5-HT in the middle meningeal artery of the anaesthetised cat.5-羟色胺诱导麻醉猫脑膜中动脉扩张。
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jun;369(6):591-601. doi: 10.1007/s00210-004-0935-4. Epub 2004 May 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验